BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Halozyme Therapeutics, Inc. Announces Roche Doses First Patient in Phase 3 Clinical Trial with Subcutaneous Herceptin(R)

  October 22, 2009

   · 

  1 min read
• Drug Development

  Cell Therapeutics, Inc.: Pixantrone Produces High Rates of Complete Remission in Multiple Relapsed and Refractory Indolent and Aggressive Non-Hodgkin’s Lymphoma Overview of Phase II-III Clinical Trials will be Presented at International Lymphoma Meeting

  October 22, 2009

   · 

  3 min read
• Policy

  Cephalon, Inc. Notified of Generic Filing for Armodafinil Tablets

  October 22, 2009

   · 

  4 min read
• Business

  Celera Corporation Third Quarter Fiscal 2009 Results and Conference Call Scheduled for October 28, 2009

  October 22, 2009

   · 

  1 min read
• FDA

  Response Biomedical Obtains Special 510(k) U.S. FDA Clearance to Add Analytical Reactivity Information for the 2009 H1N1 Influenza A Virus to the RAMP(R) Influenza A/B Assay Package Insert

  October 22, 2009

   · 

  5 min read
• Job Trends

  Ameritox, Ltd. to Open in Greensboro, to Hire 228

  October 22, 2009

   · 

  1 min read
• Deals

  GE Healthcare to Purchase Assets of ONI Medical Systems, Inc. Provider of World’s Only High-Field Dedicated Extremity MRI Scanners

  October 22, 2009

   · 

  5 min read
• Deals

  Entest Biomedical, Inc. Announces Intent to Acquire Cancer Research Company Therinject

  October 22, 2009

   · 

  1 min read
• Policy

  Sinovac Biotech Ltd. Receives Certificate of Approval to Distribute PANFLU.1 (H1N1) in Mexico First China-Developed Vaccine Approved for Human Use in Mexico

  October 22, 2009

   · 

  3 min read
• Pharm Country

  General Electric Company Plans $250 Million in Health Venture Investing

  October 22, 2009

   · 

  1 min read